ArticleIntensive care medicine experimental2026
Milrinone and levosimendan improve microvascular perfusion in septic rats: a randomized, placebo-controlled trial.
Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of vasopressin and its analogues on microcirculatory perfusion: a systematic review.Intensive care medicine experimental · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundMicrocirculatory dysfunction is a key pathophysiological feature of sepsis and contributes to organ failure and mortality. In the gastrointestinal tract, impaired barrier function due to microcirculatory injury promotes translocation of inflammatory mediators and bacteria, worsening systemic inflammation and multiorgan dysfunction. Inotropic and vasoactive agents may improve microvascular perfusion through vasodilation in addition to their inotropic effects. Milrinone, a phosphodiesterase-3 inhibitor, and levosimendan, a calcium sensitizer, have shown promising but inconsistent effects in sepsis, while data on their direct microcirculatory and mitochondrial effects in abdominal organs remain limited. Sub-therapeutic vasopressin has demonstrated beneficial effects on gut microcirculation in experimental models, but its combination with inotropes has not been investigated. We hypothesized that (1) milrinone and levosimendan increase colonic and hepatic microvascular blood flow and oxygenation, (2) adjunctive low-dose vasopressin further enhances gastrointestinal microcirculation, and (3) mitochondrial respiration does not differ between treatment groups.
methodsMale Wistar rats (n = 105) underwent colon ascendens stent peritonitis (CASP) or sham surgery to induce moderate sepsis. Twenty-four hours later, animals received intravenous infusions of vehicle, milrinone, levosimendan, or the respective inotrope with low-dose vasopressin. Colonic and hepatic microvascular oxygenation and blood flow were assessed using tissue-reflectance spectrophotometry and laser Doppler flowmetry. Mitochondrial respiration in colonic and hepatic tissue homogenates from septic animals was analyzed by respirometry. Statistical analyses included mixed-effects models with Tukey or Dunnett post-hoc tests and Kruskal-Wallis tests with Dunn's correction, using a two-sided significance level of α = 0.05.
resultsIn septic animals, milrinone and levosimendan increased colonic and hepatic microvascular blood flow. With adjunctive vasopressin, colonic perfusion remained increased, whereas hepatic blood flow did not increase. Microvascular oxygenation remained unchanged in both organs. In sham-operated animals, microvascular blood flow and oxygenation did not differ between treatment groups. Mitochondrial respiration in colon and liver was unchanged across treatments, as indicated by respiratory control index and ADP/O ratio.
conclusionsIn experimental abdominal sepsis, milrinone and levosimendan increase colonic and hepatic microvascular blood flow without affecting mitochondrial respiration. Adjunctive vasopressin alters hepatic but not colonic microvascular responses during combined inotropic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.